BECTON, DICKINSON AND COMPANY Sale Leaseback Transaction, Gross Proceeds, Investing Activities
BECTON, DICKINSON AND COMPANY (BDX) reported Sale Leaseback Transaction, Gross Proceeds, Investing Activities of $91.00 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:SaleLeasebackTransactionGrossProceedsInvestingActivities · last filed 2021-08-05
- BECTON, DICKINSON AND COMPANY sale leaseback transaction, gross proceeds, investing activities for the quarter ending 2021-06-30 was $91.00M.
| Period end | Sale Leaseback Transaction, Gross Proceeds, Investing Activities 3 month |
|---|---|
| 2021-06-30 | $91.00M 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |